Latest fromStock Takes
Stock Takes: Market braces for earnings decline, Mainfreight shines
Mainfreight and the gift that keeps on giving
Stock Takes: Life in the fast lane - the auto stocks bucking NZ’s downtrend
And will new car dealership Armstrong’s try listing on the sharemarket again?
Stock Takes: How much did telephone directory Yellow sell for?
And the Kiwi at the centre of a major Australian takeover stoush.
Stock Takes: Why a $4 billion deal fell over
The failed Ebos deal would have been a big bite for investors.
Stock Takes: What’s eating Fisher & Paykel Healthcare?
Since June 30, Fisher & Paykel Healthcare's stock has fallen by 14 per cent.
Pipe nightmare: Fletcher Building shares expected to fall
The company's pipe business has turned into a nightmare.
Stock Takes: Synlait’s big reveal, Fisher and Paykel's investor day
More light will be shed on the state of play with cash-strapped Synlait Milk on Monday.
Stock Takes: High interest rates versus stocks
High interest rates are making their presence felt on NZ share prices.
The economic conditions the next Government will have to contend with
How much can an incoming government afford?
Stock Takes: Call for Pacific Edge board shake-up
Plus: Vend's financial result under new ownership.
Stock Takes: NZ Shareholders Association on seeing the wood for the trees
The NZSA has questioned the timeliness of PGW's disclosure.
Is this tech company the next Xero?
This freshly listed tech start-up is back by Sir Owen Glenn.
Fix or float? Keys to the RBNZ’s next OCR move
An economist's best guess of the RBNZ’s next rate move.
'NZ is in a tough patch': Why our economy is looking like the US during the GFC
Fisher Funds' Ashley Gardyne weighs in on how markets have performed.
'Make money, or be right? - an investor’s recession dilemma
A market bull picks recession-proof stocks.
Auckland airport share sale: Ratepayers could end up being short-changed
Council's compromise might have just delivered Aucklanders the worst of two worlds.
Why is there such a dearth of companies listing on the NZX?
It has been months since the last listing on the NZ Stock Exchange.
Stock Takes: Aussies line up for Good Spirits bars
Plus: Michael Wood's mixed bag of shares, and life after Marsden Point.
How this NZ pharma firm prices drugs to avoid villain status
This NZ drug maker says it puts health above wealth.
No easy fix for high inflation environment
Fisher Funds portfolio manager Matt Peek talks about the impact of the Budget.
A capital raise for Synlait - or something more radical for balance sheet woes?
Stock Takes: Is the underperforming Synlait Milk heading toward another capital raise?